Cite
MLA Citation
Maria Dorn-Rasmussen et al.. “Drug Levels Associated With Optimal Discrimination Between Remission and Nonremission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease.” Therapeutic drug monitoring, vol. 44, no. 2, 2022, pp. 290–300. http://access.bl.uk/ark:/81055/vdc_100151269392.0x000049